FDG PET/CT Predicts Stem Cell Transplant Response in Lymphoma
Lesions detected by FDG PET/CT can predict success of stem cell transplant in patients with aggressive lymphoma.
Imaging with FDG PET/CT among patients with aggressive lymphoma can help predict response to stem cell transplant, according to a study published in Radiology.
Researchers from Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College in New York, NY, performed a retrospective review study to determine the prognostic value of performing FDG PET/CT before allogeneic and autologous stem cell transplantation (SCT) in patients with aggressive lymphoma.
One-hundred-seventy-five patients with aggressive lymphoma who underwent allogeneic or autologous SCT between January 2005 and December 2010 participated in the study. The FDG PET/CT imaging of between mid-skull and upper thigh was performed within the three-month period before the transplantation; 73 patients underwent FDG PET/CT before [[{"type":"media","view_mode":"media_crop","fid":"44068","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_90076324399","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4904","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 120px; width: 160px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]allogeneic SCT and 102 patients underwent FDG PET/CT before autologous SCT. The researchers evaluated the PET/CT images for lesions with FDG avidity greater than that of the background liver.
The results showed that before allogeneic SCT, 23 of 73 patients (32%) had FDG-avid lesions, and before autologous SCT, 11 of 102 patients (11%) had FDG-avid lesions.
Two-year progression-free survival:
“Similar differences were seen in overall survival and disease-specific survival,” the authors wrote. “The risk for post-transplantation recurrence correlated with higher lesional maximum standardized uptake values: for PFS, P < .0001 to P = .01; for DSS, P < .0001 to P = .002; and for OS, P < .0001 to P = .015.”
The researchers concluded that performing FDG PET/CT before SCT in patients with aggressive lymphoma has prognostic value and gives physicians a better indication of the likelihood of SCT success.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
